HRES 1274
117th Congress
House
Health
Congressional-executive branch relations
Drug trafficking and controlled substances
Executive Office of the President
Government information and archives
Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.
Everywhere this bill has been
8 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 29, 2022
Placed on the House Calendar, Calendar No. 133.
Sep 29, 2022
Reported by the Committee on Energy and Commerce. H. Rept. 117-527.
Sep 21, 2022
Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.
Sep 21, 2022
Committee Consideration and Mark-up Session Held.
Sep 21, 2022
Subcommittee on Health Discharged.
Jul 27, 2022
Referred to the Subcommittee on Health.
Jul 26, 2022
Referred to the House Committee on Energy and Commerce.
Jul 26, 2022
Introduced in House
Plain-English summary
This resolution directs the President to provide, within 14 days, certain information and documents concerning communications between the Department of Health and Human Services, the White House, the Department of Justice, and other agencies about recommendations for reducing the supply of illicitly manufactured fentanyl-related substances.
What's happening now
Placed on the House Calendar, Calendar No. 133.
Committees of jurisdiction
2
Cosponsors
1